Intravitreal Ranibizumab or Aflibercept After Bevacizumab in Diabetic Macular Edema: Exploratory Retrospective Analysis

AIM: To evaluate the efficacy of switching from bevacizumab to ranibizumab or aflibercept in eyes with diabetic macular edema (DME) unresponsive to bevacizumab. METHODS: Single-center retrospective comparative study of patients with DME unresponsive to intravitreal bevacizumab that was switched to ra...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Clin Ophthalmol
Glavni autori: Pessoa, Bernardete, Malheiro, Luísa, Carneiro, Inês, Monteiro, Sílvia, Coelho, João, Coelho, Constança, Figueira, João, Meireles, Angelina, Melo Beirão, João Nuno
Format: Artigo
Jezik:Inglês
Izdano: Dove 2021
Teme:
Original Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7837538/
https://ncbi.nlm.nih.gov/pubmed/33519187
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S280644
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items